Iressa Shows Promise For Treatment Of Metastatic Breast Cancer When Combined With Hormonal Therapy
May 22nd 2008Drug InformationBreast Cancer
Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers at The University of Texas M. D. Anderson Cancer Center.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
